Cabergoline, marketed under the name Dostinex in 0.5 mg doses, functions as a dopaminergic D2 receptor agonist, sourced from ergot fungi. It's primarily recognized as a prolactin inhibitor, aiding in the prevention of lactation by impeding prolactin release. Studies conducted in laboratory rats have indicated that Cabergoline elevates testosterone levels, increases muscle mass, and exhibits a negative impact on fat levels.\n\nAvailable in tablet or liquid suspension form, our product is sold as a liquid suspension containing a concentration of 0.5 mg of the active substance per milliliter. However, it's crucial to emphasize that Cabergoline Dostinex 0.5 mg is intended solely for research purposes. Any suspicion of misuse of products sold by Vision Peptides for purposes other than research or laboratory use will result in the individual being added to our no-sell list.